Product Description: AR89-d6 (Compound AR102) is a deuterated derivative of AR89 with oral activity. AR89-d6 demonstrates activity against S. mansoni, S. haematobium, and S. japonicum, and can be utilized for research on schistosomiasis[1].
Applications: COVID-19-immunoregulation
Formula: C13H7D6F3N2O2
References: [1]Leas D A, et al. Single-Dose Drug Development Candidate for Schistosomiasis[J]. ACS Infectious Diseases, 2024.
CAS Number: 3021566-15-1
Molecular Weight: 292.29
Research Area: Infection
Target: Parasite